| 2026-04-25 |
EXDO62C0281844 |
NORTHSTAR DISTRIBUTION CENTER 8912 |
7765.0 kg |
310510.0
|
CLOPIDOGREL USP MG TABLETS NSTR HTS: |
| 2026-04-25 |
IGLBMU31277MDSAV |
MACLEODS PHARMA USA INC |
8847.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P TRIAMCINOL ONE ACETONIDE CREAM USP . WW HSN: NYSTATIN CREAM USP UNITS PER GRAM G HSN: NYSTATIN CREAM UNIT GM GM HSN: NYSTATIN AND TRIAMCINOLONE ACETONIDE OINTMENT USP , UNITS MG HSN : NYSTATI |
| 2026-04-25 |
IGLBMU31319MDSAV |
MACLEODS PHARMA USA INC |
6396.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P OLANZAPINE TABLETS USP MG C HSN: OLANZAPI NE ODT MG TABLETS MONTELUKAST SODIUM CHEWAB LE TABLETS MG CT HSN: AMLODIPIN E MG AND OLMESARTAN MG TABLETS : HSN: OSELTAMIVIR USP MG CAPSULES HSN: ME |
| 2026-04-25 |
IGLBMU31324MDSAV |
MACLEODS PHARMA USA INC |
7684.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P OLANZAPINE TABLETS USP MG CT HSN: OLANZAP INE TABLETS USP MG CT HSN: OL MESARTAN MEDOXOMIL TABLETS, USP MG USA S COUNT CONTAINER PAC HSN: AMLODIPINE MG AND OLMESARTAN MG TABLETS HSN: |
| 2026-04-25 |
IGLBMU31323MDSAV |
MACLEODS PHARMA USA INC |
8657.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P OLANZAPINE TABLETS USP MG CT HSN: PIOGLIT AZONE AND METFORMIN HYDROCHLORIDE TABLETS,USPMGMG USA S COUNT HSN: OLMESA RTAN MEDOXOMIL TABLETS, USP MG USA S COU NT CONTAINER PAC HSN: TAMSULOSIN H |
| 2026-04-25 |
IGLBMU31325MDSAV |
MACLEODS PHARMA USA INC |
14329.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P TRIAMCINOL ONE ACETONIDE CREAM USP . WW HSN CODE: |
| 2026-04-25 |
IGLBMU31263MDSAV |
MACLEODS PHARMA USA INC |
8006.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P PIOGLITAZO NE AND METFORMIN HYDROCHLORIDE TAB,USP MG MG USA S HSN: PIOGLITAZONE AND ME TFORMIN HYDROCHLORIDE TAB USP MGMG USA S HSN: OLMESARTAN MEDOXOMIL TABLET S, USP MG USA S COUNT CONTAINE |
| 2026-04-15 |
NXGWICDDKF57871 |
MACLEODS PHARMA USA INC |
4571.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-15 |
NXGWICDDKF58814 |
MACLEODS PHARMA USA INC |
4571.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-15 |
NXGWICDDKF60704 |
MACLEODS PHARMA USA INC |
4524.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-15 |
NXGWICDDKG50783 |
MACLEODS PHARMA USA INC |
4336.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-15 |
NXGWICDDKH44513 |
MACLEODS PHARMA USA INC |
7155.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-15 |
NXGWICDDKH50754 |
MACLEODS PHARMA USA INC |
11141.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-15 |
NXGWICDDKH52154 |
MACLEODS PHARMA USA INC |
5384.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-15 |
NXGWICDDKH52983 |
MACLEODS PHARMA USA INC |
8485.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-15 |
NXGWICDDKH54092 |
MACLEODS PHARMA USA INC |
7379.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-13 |
SQXNBOMS26029589 |
MACLEODS PHARMA USA INC |
7179.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-04-13 |
SQXNBOMS26029591 |
MACLEODS PHARMA USA INC |
6931.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-04-13 |
SQXNBOMS26029587 |
MACLEODS PHARMA USA INC |
6838.0 kg |
300510.0
|
PHARMACEUTICAL |
| 2026-04-13 |
SQXNBOMS26039729 |
MACLEODS PHARMA USA INC |
8680.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-04-13 |
SQXNBOMS26029562 |
MACLEODS PHARMA USA INC |
7771.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-04-13 |
SQXNBOMS26039731 |
MACLEODS PHARMA USA INC |
8461.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-04-12 |
DMALDELA55179 |
CATERPILLAR INC |
10979.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS AS PER INVOICE NO P |
| 2026-04-12 |
DMALDELA55180 |
CATERPILLAR INC |
12481.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS AS PER INVOICE NO P |
| 2026-04-09 |
NXGWICDDJY82860 |
MACLEODS PHARMA USA INC |
6396.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-04-06 |
IGLBMU31151MDSAV |
MACLEODS PHARMA USA INC |
13888.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P TRIAMCINOL ONE ACETONIDE CREAM USP . WW HSN: TRIAMCINOLONE ACETONIDE CREAM USP . WW : HS N: |
| 2026-04-06 |
IGLBMU31155MDSAV |
MACLEODS PHARMA USA INC |
6980.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P TRIAMCINOL ONE ACETONIDE CREAM USP . WW : HSN: FLUOCINONIDE TOPICAL SOLUTION .% ML BO TTLE HSN: LIDOCAINE OINTMENT USP H SN: REPAGLINIDE TABLETS USP MG S COUNTS HSN: REPAGLINIDE TABLETS USP M |
| 2026-04-06 |
IGLBMU31128MDSAV |
MACLEODS PHARMA USA INC |
9804.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P CLOBETASOL PROPIONATE TOPICAL SOLUTION USP . WW : HS N: TRIAMCINOLONE ACETONIDE CREAM USP . WW : HSN: FLUOCINONIDE TOPICAL SOLUTION .% ML BOTTLE HSN: REPA GLINIDE TABLETS USP .MG S COUNTS: HS |
| 2026-04-05 |
SQXNBOMS26029430 |
MACLEODS PHARMA USA INC |
7487.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-04-03 |
NXGWICDDJW90010 |
MACLEODS PHARMA USA INC |
18561.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC<b |
| 2026-04-03 |
NXGWICDDJY41055 |
MACLEODS PHARMA USA INC |
7572.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-30 |
IGLBMU31088MDSAV |
MACLEODS PHARMA USA INC |
6964.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT HSN: PIOGLITAZONE HYDROCHL ORIDE TABLETS USP MG PIOGLITAZONE HYDROCHL ORIDE TABLETS USP MG CT HSN: R IZATRIPTAN BENZOATE MG TABLETS HSN: PRAMIPAXOLE DIHYDROCHLORIDE EXTENDED RELEASE USP .MG TABLETS HSN: RISEDRONATE SODIUM USP MG TABLETS HSN: LOSART AN POTASSIUM MG HYDROCHLOROTHIAZIDE .MG TABLETS HSN: METHIMAZOLE TABLETS USP MG S COUNT HSN: AMLODIPINE AN D VALSARTAN TABLETS USP MGMG S HSN: |
| 2026-03-30 |
IGLBMU31089MDSAV |
MACLEODS PHARMA USA INC |
7852.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT HSN: MEMANTINE HCL MG TA BLETS HSN: PIOGLITAZONE USP MG TAB LETS HSN: PRAMIPEXOLE DIHYDROCHLORID E EXTENDED RELEASE TABLETS USP . MG HSN: RISEDRONATE SODIUM USP MG TABLETS H SN: LOSARTAN POTASSIUM MG HYDROCH LOROTHIAZIDE .MG TABLETS HSN: AML ODIPINE AND VALSARTAN TABLETS USP MGMG S HSN: |
| 2026-03-30 |
IGLBMU31090MDSAV |
MACLEODS PHARMA USA INC |
8471.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT LOSARTAN POTASSIUM AND HYDROCHLOROT HIAZIDE TABLETS USP MG. MG CT HSN: MEMANTINE HCL MG TABLETS HSN: PIOGLITAZONE HYDROCHLORIDE TABLETS USP MG CT HSN: OLMESARTAN MEDOXOMIL TABLETS, USP MG USA S COUNT HSN: NEVIRAPINE EXTENDED RELEASE MG TABLETS HSN: LOSARTAN POTASSIUM MG HYDROC HLOROTHIAZIDE .MG TABLETS HSN: ME THIMAZOLE TABLETS USP MG S COUNT HSN: CELECOXIB CAPSULES MG S COUNT C ONTAINER PACK HSN: |
| 2026-03-29 |
SQXNBOMS26028810 |
MACLEODS PHARMA USA INC |
7726.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-03-24 |
IGLBMU31030NHSAV |
MACLEODS PHARMA USA INC |
7185.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-03-23 |
EXDO62C0279993 |
NORTHSTAR DISTRIBUTION CENTER 8912 |
5756.0 kg |
520300.0
|
EMTRICITABINE MG AND TENOFOVIR HTS: |
| 2026-03-23 |
IGLBMU31084MDSAV |
MACLEODS PHARMA USA INC |
7725.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT HSN: MEMANTINE HYDROCHLORI DE MG TABLETS HSN: OLANZAPINE MG USP TABLETS HSN: PRAMIPEXOLE DIHYDR OCHLORIDE EXTENDED RELEASE TABLETS . MG CT HSN: DARIFENACIN EXTENDED:RELEASE TABLETS MG S HSN: SACUBITRIL AND VALSARTAN TABLETS MG MG |
| 2026-03-23 |
IGLBMU31087MDSAV |
MACLEODS PHARMA USA INC |
9712.0 kg |
902230.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P ATORVASTAT IN MG TABLETS QUANTITY : X X TABS ATORVASTATIN MG TABL QUANTITY : X X TABS ATORVASTATIN MG TABLETS QUANTITY : X X TABS ATORVASTATIN MG TABL ETS QUANTITY : X X TABS ATORVASTAT IN MG TABLETS QUANTITY : X X TABS ATORVASTATIN MG TABLETS QUANTITY : X X TABS ATORVASTATIN MG TABLETS QUANTI TY : X X TABS ATORVASTATIN MG TA BLETS QUANTITY : X X TABS HSN CODE: |
| 2026-03-23 |
IGLBMU31086MDSAV |
MACLEODS PHARMA USA INC |
8649.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P TRIAMCINOL ONE ACETONIDE OINTMENT USP . WW HSN: REPAGLINIDE TABLETS USP .MG S COUNTS HSN: CLOBETASOL PROPIONATE OINTMENT USP .% ALUMINUM TUBE : G CLOBETASOL PRO PIONATE OINTMENT USP .% ALUMINUM TUBE : GM CLOBETASOL PROPIONATE OINTMENT USP .% A LUMINUM TUBE : G HSN: |
| 2026-03-22 |
SQXNBOMS26029103 |
MACLEODS PHARMA USA INC |
8379.0 kg |
300510.0
|
PHARMACEUTICAL PRODUCTS |
| 2026-03-17 |
IGLBMU30983NHSAV |
MACLEODS PHARMA USA INC |
7877.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO. P IRBESARTA N MG HYDROCHLOROTHIAZIDE .MG TABLETS IRBESARTAN MG HYDROCHLOROTHIAZIDE .MG TABLETS HSN: LAMIVUDINE TABLETS, US P MG CT HSN: OLMESARTAN MEDOX OMIL AND HYDROCHLOROTHIAZIDE TABLETS MG. MG S HSN: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE TABLETS MGMG HSN: IRBESARTAN :HYDROCHLOROTHIAZIDE TAB LETS USP .MG CT HSN: FEBUXOS TAT TABLETS MG S HSN: |
| 2026-03-17 |
IGLBMU30979NHSAV |
MACLEODS PHARMA USA INC |
8499.0 kg |
280511.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO. P LEVOTHYRO XINE SODIUM TABLETS USP MCG -S LEVOTHY ROXINE SODIUM TABLETS USP MCG - S LEVO THYROXINE SODIUM TABLETS USP MCG - S LE VOTHYROXINE SODIUM TABLETS USP MCG - LEVOTHYROXINE SODIUM TABLETS USP MCG - S HSN CODE: |
| 2026-03-17 |
IGLBMU31002MDSAV |
MACLEODS PHARMA USA INC |
8490.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P PIOGLITAZO NE USP MG TABLETS HSN: OLANZAPINE .MG USP TABLETS OLANZAPINE MG USP TABLETS HSN: DARIFENACIN EXTENDED:RELEASE TA BLETS MG S HSN: |
| 2026-03-17 |
IGLBMU31017MDSAV |
MACLEODS PHARMA USA INC |
7108.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P PIOGLITAZO NE HYDROCHLORIDE TABLETS USP MG USA COMMER CIAL S HSN: OLANZAPINE MG USP TA BLETS HSN: OLANZAPINE TABLETS USP MG CT HSN: LOSARTAN POTASSIUM MG HYDROCHLOROTHIAZIDE .MG TABLETS HSN: SACUBITRIL AND VALSARTAN TABLETS M G MG USA HSN: |
| 2026-03-17 |
IGLBMU31016MDSAV |
MACLEODS PHARMA USA INC |
9373.0 kg |
310510.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P LOSARTAN A ND HYDROCHLOROTHIAZIDE TABLETS USP MG . MG CT HSN: MEMANTINE HCL MG TA BLETS HSN: PIOGLITAZONE HYDROCHLORID E TABLETS USP MG USA PIOGLITAZONE HYDROCHL ORIDE TABLETS USP MG USA HSN: PIO GLITAZONE USP MG TABLETS OLANZAPINE MG US P TABLETS OLANZAPINE MG USP TABLETS HSN: TAMSULOSIN HYDROCHLORIDE CAPSULES USP .M HSN: DARIFENACIN EXTENDED:RELEA SE TABLETS MG S HSN: SACUBITRIL AND VALSARTAN TABLETS MG MG HSN: |
| 2026-03-17 |
IGLBMU30994MDSAV |
MACLEODS PHARMA USA INC |
7600.0 kg |
291229.0
|
CARTONS IN PALLETS PHARMACEUTICAL PRO DUCTS AS PER INVOICE NO P TRIAMCINOL ONE ACETONIDE CREAM USP . WW QUANTITY : X X GM HSN CODE: LIDOCAINE OINT MENT USP HSN CODE: |
| 2026-03-12 |
NXGWICDDJJ75663 |
MACLEODS PHARMA USA INC |
7532.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-12 |
NXGWICDDJJ76864 |
MACLEODS PHARMA USA INC |
7058.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |
| 2026-03-11 |
NXGWICDDJB47961 |
MACLEODS PHARMA USA INC |
4374.0 kg |
300390.0
|
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR .) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC |